Literature DB >> 16461357

Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma.

Jianhai Jiang1, Xiaoning Chen, Jialin Shen, Yuanyan Wei, Tao Wu, Yanzhong Yang, Hanzhou Wang, Hongliang Zong, Junwu Yang, Si Zhang, Jianhui Xie, Xiangfei Kong, Weicheng Liu, Jianxin Gu.   

Abstract

beta1,4-galactosyltransferase V (GalT V; EC 2.4.1.38) can effectively galactosylate the GlcNAcbeta1-->6Man arm of the highly branched N-glycans that are characteristic of glioma. Previously, we have reported that the expression of GalT V is increased in the process of glioma. However, currently little is known about the role of GalT V in this process. In this study, the ectopic expression of GalT V could promote the invasion and survival of glioma cells and transformed astrocytes. Furthermore, decreasing the expression of GalT V in glioma cells promoted apoptosis, inhibited the invasion and migration and the ability of tumor formation in vivo, and reduced the activation of AKT. In addition, the activity of GalT V promoter could be induced by epidermal growth factor, dominant active Ras, ERK1, JNK1, and constitutively active AKT. Taken together, our results suggest that GalT V functioned as a novel glioma growth activator and might represent a novel target in glioma therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461357     DOI: 10.1074/jbc.M504489200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Hsc70 Interacts with β4GalT5 to Regulate the Growth of Gliomas.

Authors:  Guan Sun; Ying Cao; Xueliang Dai; Min Li; Jun Guo
Journal:  Neuromolecular Med       Date:  2019-01-03       Impact factor: 3.843

2.  Involvement of Galectin-3 with vascular cell adhesion molecule-1 in growth regulation of mouse BALB/3T3 cells.

Authors:  Tomomi Tadokoro; Masahiko Ikekita; Tosifusa Toda; Hiroko Ito; Takeshi Sato; Ryunosuke Nakatani; Yu Hamaguchi; Kiyoshi Furukawa
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

3.  Radiosensitisation of human glioma cells by inhibition of β1,6-GlcNAc branched N-glycans.

Authors:  Li Shen; Xiao-Xia Dong; Jun-Bo Wu; Li Qiu; Qi-Wen Duan; Zhi-Guo Luo
Journal:  Tumour Biol       Date:  2015-11-03

4.  Functional interaction of E1AF and Sp1 in glioma invasion.

Authors:  Jianhai Jiang; Yuanyan Wei; Jialin Shen; Dan Liu; Xiaoning Chen; Jin Zhou; Hongliang Zong; Xiaojing Yun; Xiangfei Kong; Si Zhang; Yanzhong Yang; Jianxin Gu
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 5.  The dynamic brain N-glycome.

Authors:  Thomas S Klarić; Gordan Lauc
Journal:  Glycoconj J       Date:  2022-03-25       Impact factor: 2.916

6.  High expression of β3GnT8 is associated with the metastatic potential of human glioma.

Authors:  Jun Liu; Li Shen; Lingyan Yang; Shuijun Hu; Lan Xu; Shiliang Wu
Journal:  Int J Mol Med       Date:  2014-04-08       Impact factor: 4.101

7.  "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Christopher McGovern; Eric Wafula; Claude dePamphilis; Morgan Meckley; Joyce Wong; Luke Stewart; Christopher D'Jamoos; Naomi Altman; Yuka Imamura Kawasawa; Zhen Du; Loren Honaas; Thomas Abraham
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

8.  Association between one-carbon metabolism indices and DNA methylation status in maternal and cord blood.

Authors:  Anna K Knight; Hea Jin Park; Dorothy B Hausman; Jennifer M Fleming; Victoria L Bland; Gisselle Rosa; Elizabeth M Kennedy; Marie A Caudill; Olga Malysheva; Gail P A Kauwell; Andrew Sokolow; Susan Fisher; Alicia K Smith; Lynn B Bailey
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

9.  Downregulation of β1,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation.

Authors:  Shu-Fen Li; Cui-Song Zhu; Yu-Meng Wang; Xin-Xin Xie; Liu-Ling Xiao; Zhi-Chun Zhang; Qi-Qun Tang; Xi Li
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.